Work

Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.11106

Authors: Komal L. Jhaveri, Eleonora Teplinsky, Rezina Arju, Shah Giashuddin, Yasmeen Sarfraz, Melissa Alexander, Farbod Darvishian, Deborah Silvera, Paul H Levine, Salman Hashmi, Heather J. Hoffman, Baljit Singh, Judith D Goldberg, Tsivia Hochman, Amanda Valeta, Robert Schneider

Institutions: New York University, Brooklyn Hospital Center, NYU Langone Health, George Washington University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589561080

Cites:

Cited by:

Related to: 10